Skip to content
Search
By   Matt Bance, CFA

Monthly Asset Allocation Update – February 2026

Our latest market perspectives and portfolio positioning insights

February 2026

View Transcript

Hi, I’m Matt Bance, and welcome to our February ‘26 asset allocation update. I’ll briefly outline how portfolios are positioned and highlight some of the key changes we’ve been making.

Firstly, starting with the overall shape of portfolios.

We continue to hold a modest overweight to risk assets, including equities. Over the past month, we’ve added to existing equity positions, and maintain higher than benchmark allocations in high yield and emerging market debt.

This reflects what we see as a supportive economic backdrop. Fiscal policy is helping to drive a re-acceleration in growth, manufacturing activity is recovering, and that should continue to support corporate earnings. We do recognise that valuations are elevated, and we expect ongoing geopolitical noise. But for us, that’s largely something to fade, not a reason to change the broader trend.

Second, we see attractive opportunities across emerging markets.

Within equities, we believe emerging markets are well positioned, benefiting from strong AI-related demand, their role as commodity producers in several key markets, and the prospect of a weaker dollar.

In fixed income, stronger currencies are helping to contain inflation, giving key central banks room to cut rates. This creates a supportive environment for EM local-currency bonds.

At the same time, we have rotated some exposure from global high yield into EM dollar-denominated debt.  All-in yields remain attractive, and spreads continue to offer a meaningful pick-up versus US corporate credit, especially in higher-yielding segments. Third, we have increased our overweight to small cap equities.

While there have been several false starts for small caps in recent years, we are now seeing a clear inflection in both trailing and forward earnings, which had been missing previously.

Importantly, the lagged effects of earlier policy easing are beginning to feed through, supporting manufacturing activity, and further expected rate cuts later this year should provide additional tailwinds.

Thanks very much for joining us, and we look forward to updating you again next month.

 

31 January 2026

* For pairwise decisions in style, market capitalisation (size) and currencies, positioning within boxes represents positioning in the first‑mentioned asset
class relative to the second asset class.

T. Rowe Price Europe and UK Regional Investment Committees inform the global asset allocation views. This material is not intended to be investment advice or a recommendation to take any particular investment action.

As of 31 January 2026.

Transcript

Hi, I’m Matt Bance, and welcome to our February ‘26 asset allocation update. I’ll briefly outline how portfolios are positioned and highlight some of the key changes we’ve been making.

Firstly, starting with the overall shape of portfolios.

We continue to hold a modest overweight to risk assets, including equities. Over the past month, we’ve added to existing equity positions, and maintain higher than benchmark allocations in high yield and emerging market debt.

This reflects what we see as a supportive economic backdrop. Fiscal policy is helping to drive a re-acceleration in growth, manufacturing activity is recovering, and that should continue to support corporate earnings. We do recognise that valuations are elevated, and we expect ongoing geopolitical noise. But for us, that’s largely something to fade, not a reason to change the broader trend.

Second, we see attractive opportunities across emerging markets.

Within equities, we believe emerging markets are well positioned, benefiting from strong AI-related demand, their role as commodity producers in several key markets, and the prospect of a weaker dollar.

In fixed income, stronger currencies are helping to contain inflation, giving key central banks room to cut rates. This creates a supportive environment for EM local-currency bonds.

At the same time, we have rotated some exposure from global high yield into EM dollar-denominated debt.  All-in yields remain attractive, and spreads continue to offer a meaningful pick-up versus US corporate credit, especially in higher-yielding segments. Third, we have increased our overweight to small cap equities.

While there have been several false starts for small caps in recent years, we are now seeing a clear inflection in both trailing and forward earnings, which had been missing previously.

Importantly, the lagged effects of earlier policy easing are beginning to feed through, supporting manufacturing activity, and further expected rate cuts later this year should provide additional tailwinds.

Thanks very much for joining us, and we look forward to updating you again next month.

Matt Bance, CFA Solutions Strategist
Feb 2026 Investment Insight

Global Asset Allocation: The View From Europe

Discover the latest global market themes
By   Yoram Lustig, CFA, PRM™
Jan 2026 Investment Insight

Global Asset Allocation: The View From Europe

Discover the latest global market themes
By   Yoram Lustig, CFA, PRM™

 

IMPORTANT INFORMATION

This material is being furnished for general informational and/or marketing purposes only. The material does not constitute or undertake to give advice of any nature, including fiduciary investment advice, nor is it intended to serve as the primary basis for an investment decision. Prospective investors are recommended to seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services. Past performance is not a reliable indicator of future performance. The value of an investment and any income from it can go down as well as up. Investors may get back less than the amount invested.

The material does not constitute a distribution, an offer, an invitation, a personal or general recommendation or solicitation to sell or buy any securities in any jurisdiction or to conduct any particular investment activity. The material has not been reviewed by any regulatory authority in any jurisdiction.

Information and opinions presented have been obtained or derived from sources believed to be reliable and current; however, we cannot guarantee the sources' accuracy or completeness. There is no guarantee that any forecasts made will come to pass. The views contained herein are as of the date noted on the material and are subject to change without notice; these views may differ from those of other T. Rowe Price group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price.

The material is not intended for use by persons in jurisdictions which prohibit or restrict the distribution of the material and in certain countries the material is provided upon specific request.  

It is not intended for distribution to retail investors in any jurisdiction.

202602-5183964